Efficacy and safety of cisplatin, dexamethasone, gemcitabine and pegaspargase (DDGP) regimen in newly diagnosed, advanced-stage extranodal natural killer/T-cell lymphoma: interim analysis of a phase 4 study NCT01501149
Lei Zhang(Union Hospital), Mingzhi Zhang(Chinese Academy of Sciences), Wencai Li(First Affiliated Hospital of Zhengzhou University), Jia Sisi(First Affiliated Hospital of Zhengzhou University), Yangyang Ma(First Affiliated Hospital of Zhengzhou University), Yanru Qin(First Affiliated Hospital of Zhengzhou University), Dandan Zhang(Qingdao University), Xinhua Wang(Zhengzhou University), Xudong Zhang(Southwest University of Science and Technology), Wang Ma(First Affiliated Hospital of Zhengzhou University), Guannan Wang(Harvard University), Xin Li(Harbin Medical University), Hong‐Wei Xue(South China Agricultural University), Jingjing Wu(Beijing Tian Tan Hospital), Jiaqin Yan(First Affiliated Hospital of Zhengzhou University), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Liping Su, Yu Chang(Jilin University), Feifei Nan(First Affiliated Hospital of Zhengzhou University), Ling Li(First Affiliated Hospital of Zhengzhou University), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Jinghua Wang(Beijing Tongren Hospital), Ken H. Young(Duke Medical Center)
Cited by 19
Related Papers
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
|Journal of Clinical Oncology|2012|682
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
|Proceedings of the National Academy of Sciences|2011|644
Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell Lymphoma
|Journal of Clinical Oncology|2015|418